LMMY
Exousia Bio, Inc.
Key Financials
Operating Income
$-56421
↓ 5921.5%
Net Income
$51395
↑ 299.2%
Gross Profit
$-3501
↓ 291.0%
Revenue
$3750
↓ 67.4%
EPS (Diluted)
$0.00
NaN%
Total Liabilities
$0.00
↓ 100.0%
Shareholders' Equity
$0.00
↑ 100.0%
Cash & Equivalents
$7855.00
↓ 22.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 8/31/2026 | View on SEC |
| 10-Q | 6/16/2026 | View on SEC |
| NT 10-Q | 4/14/2026 | View on SEC |
| 10-Q | 3/17/2026 | View on SEC |
| NT 10-Q | 1/15/2026 | View on SEC |
| 8-K | 11/17/2025 | View on SEC |
| 10-Q | 11/17/2025 | View on SEC |
| 10-K | 10/17/2025 | View on SEC |
| NT 10-Q | 10/16/2025 | View on SEC |
| NT 10-K | 8/29/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LMMY |
| Company Name | Exousia Bio, Inc. |
| CIK | 1939937 |
| Sector | Services-Educational Services |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 8200 |
| SIC Description | Services-Educational Services |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | WY |
| Phone | 940-367-6154 |